↓ Skip to main content

PLOS

MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels

Overview of attention for article published in PLOS ONE, September 2011
Altmetric Badge

Mentioned by

twitter
1 X user
patent
3 patents

Citations

dimensions_citation
207 Dimensions

Readers on

mendeley
87 Mendeley
Title
MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels
Published in
PLOS ONE, September 2011
DOI 10.1371/journal.pone.0025787
Pubmed ID
Authors

Lena M. Wulfken, Rudolf Moritz, Carsten Ohlmann, Stefan Holdenrieder, Volker Jung, Frank Becker, Edwin Herrmann, Gisela Walgenbach-Brünagel, Alexander von Ruecker, Stefan C. Müller, Jörg Ellinger

Abstract

MicroRNA expression is altered in cancer cells, and microRNAs could serve as diagnostic/prognostic biomarker for cancer patients. Our study was designed to analyze circulating serum microRNAs in patients with renal cell carcinoma (RCC).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Portugal 1 1%
Germany 1 1%
Unknown 83 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 23%
Student > Ph. D. Student 18 21%
Student > Bachelor 11 13%
Student > Doctoral Student 9 10%
Student > Master 7 8%
Other 17 20%
Unknown 5 6%
Readers by discipline Count As %
Agricultural and Biological Sciences 31 36%
Medicine and Dentistry 29 33%
Biochemistry, Genetics and Molecular Biology 6 7%
Veterinary Science and Veterinary Medicine 2 2%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 9 10%
Unknown 8 9%